Loading…
Japan's Kaneka Corporation announced the acquisition of 96.8% of shares of Israeli medical device company EndoStream Medical, which develops the Nautilus device for aneurysm treatment. The deal is valued at an estimated $100 million, and Kaneka plans to jointly develop and manufacture new cerebrovascular devices, targeting over $120 million in sales by 2030.